DD128130A5 - Verfahren zur herstellung neuer pyrazol-derivate - Google Patents

Verfahren zur herstellung neuer pyrazol-derivate

Info

Publication number
DD128130A5
DD128130A5 DD7700196901A DD19690177A DD128130A5 DD 128130 A5 DD128130 A5 DD 128130A5 DD 7700196901 A DD7700196901 A DD 7700196901A DD 19690177 A DD19690177 A DD 19690177A DD 128130 A5 DD128130 A5 DD 128130A5
Authority
DD
German Democratic Republic
Prior art keywords
producing new
pyrazol derivatives
new pyrazol
derivatives
producing
Prior art date
Application number
DD7700196901A
Other languages
German (de)
English (en)
Inventor
Hanns Ahrens
Henning Koch
Eberhard Schroeder
Helmut Biere
Joachim-Friedrich Kapp
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2536003A external-priority patent/DE2536003C2/de
Application filed by Schering Ag filed Critical Schering Ag
Priority to DD7700196901A priority Critical patent/DD128130A5/xx
Publication of DD128130A5 publication Critical patent/DD128130A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72Hydrazones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD7700196901A 1975-08-08 1977-01-12 Verfahren zur herstellung neuer pyrazol-derivate DD128130A5 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DD7700196901A DD128130A5 (de) 1975-08-08 1977-01-12 Verfahren zur herstellung neuer pyrazol-derivate

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE2536003A DE2536003C2 (de) 1975-08-08 1975-08-08 Pyrazol-Derivate, ihre Herstellung und diese enthaltende pharmazeutische Derivate
DE19762633992 DE2633992A1 (de) 1975-08-08 1976-07-26 Neue pyrazol-derivate, ihre herstellung und verwendung
DD7700196901A DD128130A5 (de) 1975-08-08 1977-01-12 Verfahren zur herstellung neuer pyrazol-derivate
AU22014/77A AU514889B2 (en) 1975-08-08 1977-02-07 Pyrazole derivatives

Publications (1)

Publication Number Publication Date
DD128130A5 true DD128130A5 (de) 1977-11-02

Family

ID=40520846

Family Applications (1)

Application Number Title Priority Date Filing Date
DD7700196901A DD128130A5 (de) 1975-08-08 1977-01-12 Verfahren zur herstellung neuer pyrazol-derivate

Country Status (11)

Country Link
AU (1) AU514889B2 (nl)
BE (1) BE844972A (nl)
CS (3) CS216206B2 (nl)
DD (1) DD128130A5 (nl)
DE (1) DE2633992A1 (nl)
DK (1) DK147973C (nl)
GB (1) GB1562943A (nl)
HU (1) HU175423B (nl)
IE (1) IE43659B1 (nl)
LU (1) LU75548A1 (nl)
NL (1) NL188696C (nl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3203307A1 (de) * 1982-01-27 1983-07-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen Phosphonate, und diese enthaltende pharmazeutische verbindungen
US4826868A (en) * 1986-05-29 1989-05-02 Ortho Pharmaceutical Corporation 1,5-Diaryl-3-substituted pyrazoles pharmaceutical compositions and use
AU611437B2 (en) * 1987-05-29 1991-06-13 Ortho Pharmaceutical Corporation Pharmacologically active 2- and 3-substituted (1',5'-diaryl-3-pyrazolyl)-n-hydroxypropanamides and method for synthesizing the same
IT1226387B (it) * 1988-07-08 1991-01-15 Seuref Ag Processo per la preparazione di acidi 1,4-diaril-3-pirazol-acetici
US20110190365A1 (en) * 2008-08-14 2011-08-04 Bayer Crop Science Ag Insecticidal 4-phenyl-1H-pyrazoles
US9226505B2 (en) * 2011-09-23 2016-01-05 Bayer Intellectual Property Gmbh 4-substituted 1-phenylpyrazole-3-carboxylic acid derivatives as agents against abiotic plant stress
WO2015054283A1 (en) * 2013-10-08 2015-04-16 Calcimedica, Inc. Compounds that modulate intracellular calcium

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE755924A (fr) * 1969-09-12 1971-02-15 Byk Gulden Lomberg Chem Fab Derives d'acide pyrazole-4-acetique, leur procede de preparation et medicaments en contenant
DE2347015C2 (de) * 1973-09-14 1985-12-12 Schering AG, 1000 Berlin und 4709 Bergkamen Neue Pyrazolyloxyessigsäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende Mittel

Also Published As

Publication number Publication date
BE844972A (fr) 1977-02-07
CS216206B2 (en) 1982-10-29
CS216207B2 (en) 1982-10-29
LU75548A1 (nl) 1977-03-25
IE43659B1 (en) 1981-04-22
DE2633992C2 (nl) 1988-04-28
DK147973C (da) 1985-07-08
CS216205B2 (en) 1982-10-29
DK147973B (da) 1985-01-21
HU175423B (hu) 1980-07-28
IE43659L (en) 1977-02-08
GB1562943A (en) 1980-03-19
DE2633992A1 (de) 1978-02-09
NL188696B (nl) 1992-04-01
NL188696C (nl) 1992-09-01
AU2201477A (en) 1978-08-17
DK356676A (da) 1977-02-09
NL7608810A (nl) 1977-02-10
AU514889B2 (en) 1981-03-05

Similar Documents

Publication Publication Date Title
AT359217B (de) Verfahren zur herstellung neuer peptid-derivate
DD127900A5 (de) Verfahren zur herstellung von mercaptoazetidin-derivaten
AT362364B (de) Verfahren zur herstellung neuer phenylimi- dazolidinonderivate
AT342770B (de) Verfahren zur herstellung neuer erythromycinderivate
ATA412376A (de) Verfahren zur herstellung neuer pyrazol-triazol -oder tetrazolderivate
AT352918B (de) Verfahren zur herstellung neuer histidin- derivate
AT358601B (de) Verfahren zur herstellung neuer nitrosoharn- stoff-derivate
AT367403B (de) Verfahren zur herstellung neuer chinolin-2onderivate
DD128130A5 (de) Verfahren zur herstellung neuer pyrazol-derivate
AT357155B (de) Verfahren zur herstellung neuer imidazol- derivate
AT361639B (de) Verfahren zur herstellung von 5-androsten-17- -on-derivaten
AT359059B (de) Verfahren zur herstellung neuer 1-methyl-2- (phenyl-oxymethyl)-5-nitroimidazolderivate
AT351046B (de) Verfahren zur herstellung neuer diharnstoffe
ATA736576A (de) Verfahren zur herstellung neuer indolderivate
AT356294B (de) Verfahren zur herstellung neuer ergolinderivate
AT357516B (de) Verfahren zur herstellung neuer 2,3-dihydro- benzofuranon-2-derivate
DD133331A5 (de) Verfahren zur herstellung neuer basischer substituierter theophyllinderivate
ATA759479A (de) Verfahren zur herstellung neuer ergolinderivate
ATA759579A (de) Verfahren zur herstellung neuer ergolinderivate
AT343136B (de) Verfahren zur herstellung neuer phosphinyl-derivate
AT355027B (de) Verfahren zur herstellung neuer benzodiazepin- derivate
AT341531B (de) Verfahren zur herstellung neuer octahydropyridoindolobenzazepine
ATA700078A (de) Verfahren zur herstellung neuer vincanol- und epivincanolderivate
AT372386B (de) Verfahren zur herstellung neuer ergopeptidalkaloidderivate
AT367767B (de) Verfahren zur herstellung neuer ergopeptidalkaloidderivate

Legal Events

Date Code Title Description
PJ Ceased due to non-payment of renewal fee (addendum to changes before extension act)